Eleazar Ramírez

Prof. Dr. Eleazar Ramírez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Viral Immunology
Verified
Journal Article
Closed access
EREleazar Ramírez
Eleazar Ramírez
LHLuis Fernando Hernández-Zimbrón
Luis Fernando Hernández-Zimbrón
NZNayeli Martínez Zúñiga
Nayeli Martínez Zúñiga
JLJuan José Leal-García
Juan José Leal-García
VHVioleta Ignacio Hernández
Violeta Ignacio Hernández
EZEdgar Zenteno
Edgar Zenteno
The current pandemic is caused by the coronavirus disease 2019 (COVID-19), which is, in turn, induced by a novel coronavirus (SARS-CoV-2) that triggers an acute respiratory disease. In recent years, the emergence of SARS-CoV-2 is the third highly pathogenic event and large-scale epidemic affecting the human population. It follows the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 and the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. This novel SARS-CoV-2 employs the angiotensin-converting enzyme 2 (ACE2) receptor, like SARS-CoV, and spreads principally in the respiratory tract. The viral spike (S) protein of coronaviruses facilities the attachment to the cellular receptor, entrance, and membrane fusion. The S protein is a glycoprotein and is critical to elicit an immune response. Glycosylation is a biologically significant post-translational modification in virus surface proteins. These glycans play important roles in the viral life cycle, structure, immune evasion, and cell infection. However, it is necessary to search for new information about viral behavior and immunological host's response after SARS-CoV-2 infection. The present review discusses the implications of the CoV-2 S protein glycosylation in the SARS-CoV-2/ACE2 interaction and the immunological response. Elucidation of the glycan repertoire on the spike protein can propel research for the development of an appropriate vaccine.

3 June 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
RPRoxanna Perez-Garmendia
Roxanna Perez-Garmendia
ALAlicia López-de-Eguileta
Alicia López-de-Eguileta
IMIvan Ramos Martínez
Ivan Ramos Martínez
NZNayeli Martínez Zuñiga
Nayeli Martínez Zuñiga
RGRoberto Gonzalez-Salinas
Roberto Gonzalez-Salinas
LHLuis Fernando Hernández-Zimbrón
Luis Fernando Hernández-Zimbrón
There are different pathologies associated with amyloidogenic processes caused by the increase of reactive oxygen species (ROS) and the overactivation of inflammatory responses. These alterations are present in different regions of the anterior segment of the eye, and they have been associated with the development and progression of ocular pathologies, such as glaucoma, dry eye syndrome, keratitis, and cataracts among other pathologies. Aim. To discuss briefly the anatomical characteristics of the anterior segment of the eye and describe the interaction between oxidative stress (OS) and inflammatory responses, emphasizing the misfolding of several proteins leading to amyloidogenic processes occurring in the anterior segment and their implications in the development of ocular diseases. We performed a search on PubMed, CINAHL, and Embase using the MeSH terms “eye,” “anterior segment”, “inflammation”, “oxidative stress”, and “amyloidosis”. The search encompassed manuscripts published up to April 2019. A hundred forty-four published studies met the inclusion criteria. We present the current knowledge regarding the interaction between OS and the activation of inflammatory processes and how both can cause conformational changes in several peptides and proteins in each compartment of the anterior segment. However, we found that there is no consensus about which factor is the first to cause amyloidosis. Our conclusions suggest that there is an interplay among these factors forming a vicious cycle that leads to the loss of protein structure in ocular pathologies, and multifactorial therapies should be developed to avoid protein misfolding and to stop the progression of ocular pathologies.

2 June 2022 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
EREleazar Ramírez
Eleazar Ramírez
BOBeatriz Alanis Olvera
Beatriz Alanis Olvera
DGDaniela Carmona González
Daniela Carmona González
OMOscar Guerrero Marín
Oscar Guerrero Marín
DMDenisse Pantoja Mercado
Denisse Pantoja Mercado
EZEdgar Zenteno
Edgar Zenteno

1 March 2021 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
IRIvan Ramos-Martínez
Ivan Ramos-Martínez
OVOscar Vivanco-Rojas
Oscar Vivanco-Rojas
BJBrenda Juárez-Domínguez
Brenda Juárez-Domínguez
LHLuis Hernández-Zimbrón
Luis Hernández-Zimbrón
LPLenin Ochoa-De la Paz
Lenin Ochoa-De la Paz
EZEdgar Zenteno
Edgar Zenteno
Purpose: In order to better understand cataract development, we analyzed the glycosylation profile of human lens epithelial cells (HLECs) from anterior lens capsules of type 2 diabetes mellitus (T2DM) and non-diabetic (ND) patients undergoing routine cataract surgery. Setting: Research Department of the Asociación para Evitar la Ceguera, Hospital “Dr. Luis Sánchez Bulnes”, Mexico. Design: Experimental study. Methods: Evaluation of anterior lens capsules from T2DM and ND patients undergoing phacoemulsification and free from other ocular diseases. Results: Hematoxylin-eosin staining revealed HLECs alterations in T2DM samples. From lectins with different sugar specificities used, concanavalin A showed significant differences, labeling homogeneously both in the cytoplasm and in cell membranes in ND capsules, while in T2DM capsules, in addition to membrane and cytoplasm labeling, there were perinuclear vesicles with high concanavalin A labeling. Two-dimensional gel electrophoresis showed that T2DM patients have a ∼ 65-kDa spot with an isoelectric point of 5.5 with a higher density compared to ND capsules, and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis showed 62% homology with type-1 cytokeratin. Immunohistochemistry using anti-pan cytokeratin antibody revealed co-localization with concanavalin A, and a lectin blot revealed with concanavalin A showed a band of ∼ 65 kDa, a molecular weight that corresponds to human type 1 cytokeratin. Conclusion: These results suggest that over-expression of N-glycosidically linked human type 1 cytokeratin may induce capsule disruption and affect selective permeability, allowing the entry of different molecules to the lens that facilitate cataract progression.

14 January 2026 in Life
Verified
Journal Article
Open access
PDF file
SBSantiago Burgos-Puentes
Santiago Burgos-Puentes
AAArturo Avendaño-Estrada
Arturo Avendaño-Estrada
MSMarquiza Sablón-Carrazana
Marquiza Sablón-Carrazana
EREleazar Ramírez
Eleazar Ramírez
AJAndrea Granados Juárez
Andrea Granados Juárez
MRMiguel Angel Avila Rodriguez
Miguel Angel Avila Rodriguez
Several animal models of Alzheimer’s disease have been developed and tested for diagnostic and treatment purposes. [11C]PIB is the gold-standard radiotracer for the detection of Aβ plaque deposits, a hallmark of the disease. This study aimed to evaluate the in vivo detection of Aβ plaques using [11C]PIB microPET imaging across different animal models of Alzheimer’s disease. The study included 3xTg-AD transgenic mice, TgF344-AD transgenic rats and Aβ injection-based rat model. The results showed an age-related increase in [11C]PIB uptake in 3xTg-AD mice, particularly in the midbrain and thalamus. In TgF344-AD rats, differences were also observed compared to WT controls, with the highest values observed in the hippocampus and cortex. In the injection-based model, inoculated rats showed greater uptake in the injection site than SHAM animals. Across all microPET studies, [11C]PIB uptake was consistently higher in females than in their male counterparts. These findings support the value of transgenic and Aβ injection-based models in preclinical research on Aβ plaque deposition and highlight the importance of considering species, model type, sex, and age in experimental design.

15 November 2022 in Blood
Verified
Journal Article
Open access
LMLuis Mario Villela Martinez
Luis Mario Villela Martinez
BBBrady E. Beltrán
Brady E. Beltrán
MVMarialejandra Alejandra Torres Viera
Marialejandra Alejandra Torres Viera
HIHenry Idrobo
Henry Idrobo
MCMyrna Candelaria
Myrna Candelaria
LCLuis Enrique Malpica Castillo
Luis Enrique Malpica Castillo
Introduction. There are different biological variables associated to overall survival (OS) in Diffuse Large B-cell lymphoma (DLBCL). Anemia (Adams HJ et al 2015